Articles producció científica> Bioquímica i Biotecnologia

The effect of the Mediterranean diet on plasma brain-derived neurotrophic factor (BDNF) levels: The PREDIMED-NAVARRA randomized trial

  • Identification data

    Identifier: PC:3182
    Authors:
    Jordi Salas-SalvadóAlmudena SanchezCecilia GalbeteMiguel Angel Martinez-GonzalezAlfredo MartinezCristina RazquinRamon EstruchPilar Buil-CosialesAmelia Martí
    Abstract:
    OBJECTIVES: There are no human studies assessing the effect of nutritional interventions on plasma brain-derived neurotrophic factor (BDNF) concentrations. The aim of this study was to assess the role of a nutritional intervention based on a Mediterranean diet (MeDiet) on plasma BDNF levels. METHODS: PREvención con Dieta MEDiterránea (PREDIMED) is a randomized clinical trial designed to assess the effect of a Mediterranean diet (MeDiet) on the primary prevention of cardiovascular disease. For this analysis, 243 participants from the Navarra centre were randomly selected. Participants were assigned to one of three dietary interventions: control (low-fat) diet, MeDiet supplemented with virgin olive oil (MeDiet+VOO), or MeDiet supplemented with nuts (MeDiet+Nuts). Plasma BDNF levels were measured after 3 years of intervention. Multivariate-adjusted means of BDNF for each intervention were compared using generalized linear models. Logistic regression models were fit to assess the association between the dietary intervention and the likelihood to have low plasma BDNF values (<13 µg/ml, 10th percentile). Analyses were repeated after stratifying the sample according to baseline prevalence of different diseases. RESULTS: Higher but non-significant plasma BDNF levels were observed for participants assigned to both MeDiets. Participants assigned to MeDiet+Nuts showed a significant lower risk (odds ratios (OR)=0.22; 95% confidence intervals (CI)=0.05-0.90) of low plasma BDNF values (<13 µg/ml) as compared to the control group. Among participants with prevalent depression at baseline, significantly higher BDNF levels were found for those assigned to the MeDiet+Nuts. DISCUSSION: Adherence to a MeDiet was associated to an improvement in plasma BDNF concentrations in individuals wi
  • Others:

    Author, as appears in the article.: Jordi Salas-Salvadó; Almudena Sanchez; Cecilia Galbete; Miguel Angel Martinez-Gonzalez; Alfredo Martinez; Cristina Razquin; Ramon Estruch; Pilar Buil-Cosiales; Amelia Martí
    Department: Bioquímica i Biotecnologia
    URV's Author/s: SALAS SALVADÓ, JORGE; Almudena Sanchez; Cecilia Galbete; Miguel Angel Martinez-Gonzalez; Alfredo Martinez; Cristina Razquin; Ramon Estruch; Pilar Buil-Cosiales; Amelia Martí
    Keywords: Brain Derived Neurotrophic Factor Depression Clinical trial
    Abstract: OBJECTIVES: There are no human studies assessing the effect of nutritional interventions on plasma brain-derived neurotrophic factor (BDNF) concentrations. The aim of this study was to assess the role of a nutritional intervention based on a Mediterranean diet (MeDiet) on plasma BDNF levels. METHODS: PREvención con Dieta MEDiterránea (PREDIMED) is a randomized clinical trial designed to assess the effect of a Mediterranean diet (MeDiet) on the primary prevention of cardiovascular disease. For this analysis, 243 participants from the Navarra centre were randomly selected. Participants were assigned to one of three dietary interventions: control (low-fat) diet, MeDiet supplemented with virgin olive oil (MeDiet+VOO), or MeDiet supplemented with nuts (MeDiet+Nuts). Plasma BDNF levels were measured after 3 years of intervention. Multivariate-adjusted means of BDNF for each intervention were compared using generalized linear models. Logistic regression models were fit to assess the association between the dietary intervention and the likelihood to have low plasma BDNF values (<13 µg/ml, 10th percentile). Analyses were repeated after stratifying the sample according to baseline prevalence of different diseases. RESULTS: Higher but non-significant plasma BDNF levels were observed for participants assigned to both MeDiets. Participants assigned to MeDiet+Nuts showed a significant lower risk (odds ratios (OR)=0.22; 95% confidence intervals (CI)=0.05-0.90) of low plasma BDNF values (<13 µg/ml) as compared to the control group. Among participants with prevalent depression at baseline, significantly higher BDNF levels were found for those assigned to the MeDiet+Nuts. DISCUSSION: Adherence to a MeDiet was associated to an improvement in plasma BDNF concentrations in individuals with depression.
    Research group: Alimentació, Nutrició, Creixement i Salut Mental
    Thematic Areas: Bioquímica i biotecnologia Bioquímica y tecnología Biochemistry and technology
    licence for use: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 1028-415X
    Author identifier: ; ; ; ; ; ; ; ;
    Record's date: 2016-06-14
    Last page: 201
    Journal volume: 14
    Papper version: info:eu-repo/semantics/acceptedVersion
    Link to the original source: https://www.tandfonline.com/doi/full/10.1179/1476830511Y.0000000011
    Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/
    Article's DOI: 10.1179/1476830511Y.0000000011
    Entity: Universitat Rovira i Virgili
    Journal publication year: 2011
    First page: 195
    Publication Type: Article Artículo Article
  • Keywords:

    Factors de creixement
    Depressió psíquica
    Dieta mediterrània
    Brain Derived Neurotrophic Factor
    Depression
    Clinical trial
    Bioquímica i biotecnologia
    Bioquímica y tecnología
    Biochemistry and technology
    1028-415X
  • Documents:

  • Cerca a google

    Search to google scholar